Medicaid MCOs must use caution when reporting data November 09, 2016By Tracey WalkerFailure to report accurate data can result in significant penalties for Medicaid managed care plans. P4P programs feasible in addiction settings November 05, 2016By Tracey WalkerAlcohol and drug dependency treatment goals can tied to an insurer’s pay-for-performance incentive program. Here’s how. Insurer: No more prior auths for opioid addiction meds October 28, 2016By Tracey WalkerAs part of efforts to combat the opioid epidemic, Cigna removes prior authorization from medication-assisted treatment for opioid use disorder. Four ways clinical decision support can improve outcomes October 14, 2016By Keren Ofri MDThe advantages of using an advanced clinical decision support system fall into four general “reducing” categories. Here they are. Three ways to rein in drug costs regardless of who becomes president October 13, 2016By Marc O'ConnorIt’s time for stakeholders to cooperate in order to limit the wasted spending on prescription medications and chart a path to collectively improving value derivation. Biosimilars and interchangeable biologics: News to watch October 06, 2016By Aubrey WestgateBiosimilars in the United States are slowly gaining traction, but widespread confusion and legal barriers remain. Health execs must brace for autoimmune drug changes October 05, 2016By Tracey WalkerA comprehensive understanding of this rapidly increasing drug class is essential to integrate pharmacy and medical claim information. Four reasons why a hospital should open an integrated pharmacy September 25, 2016By Dana FoxWhen is retail right? Consider these four benefits that will impact the bottom line. Medicare Part D patients not taking blood pressure meds correctly September 20, 2016By Tracey WalkerExpert offers specific actions for managed care execs to take Providers are failing to meet needs of depressed patients September 18, 2016By Tracey WalkerA new study shows that many adults with depression don’t receive treatment, whereas others receive treatments that do not match their level of illness severity.